- This event has passed.
Presenter(s): Emily E. Leppien, PharmD, BCPS, BCPP
Target Audience: This activity is designed for pharmacists.
Webinar Description: Controlled substances, including opioids, benzodiazepines and medical cannabis, are commonly prescribed for treatment of chronic pain. Urine drug screens (UDS) are often used in clinical practice to test for the presence of prescribed drugs in an effort to monitor compliance. This application-based webinar will provide participants the opportunity to further their ability to appropriately interpret UDS results through review of real-life patient case scenarios.
- List causes that may lead to unexpected UDS results, specifically false positives and negatives.
- Discuss how opioid and benzodiazepine metabolism impacts UDS results.
- Interpret a UDS reading based on patient history and reported results.
- Recommend appropriate monitoring based on patient history and UDS results.
Requirements for successful activity completion:
In order to successfully complete this activity and obtain your Certificate, you will be required to:
- Course Content: Complete the pre-reflection question and view the recorded presentation.
- Click Survey and answer the questions to the best of your ability.
Upon completion of this survey, it will unlock and allow you to proceed to the final course evaluation.
- Click Evaluation to complete the final PCSS course evaluation.
- Following your completion of the evaluation, you will have access to your Certificate of Completion.
Note: This archive webinar is not designated for AMA PRA Category 1 Credit™.